Dongming Xing
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Pharmacology top 0.5%
- Berberine and alkaloids research
- Flavonoids in Medical Research
Papers in
-
- Ubiquitin and proteasome pathways 13
- Protein Degradation and Inhibitors 13
- Natural product bioactivities and synthesis 12
- Advanced biosensing and bioanalysis techniques 11
- Pharmacology 36
- Berberine and alkaloids research 9
- Co-authors
- Lijun Du (61 shared papers)Wujun Chen (44 shared papers)Zhimin Lu (11 shared papers)Daqian Xu (6 shared papers)Bing Liang (32 shared papers)Xueli Bian (3 shared papers)Rui Liu (2 shared papers)Ying Meng (1 shared paper)
- Journals
- Tsinghua Science & Technology (7 papers)Biomedical Chromatography (7 papers)Frontiers in Immunology (6 papers)European Journal of Medicinal Chemistry (6 papers)Chinese Journal of Natural Medicines (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dongming Xing
216 papers receiving 6.9k citations
Dongming Xing's Hit Papers
Peers
Comparison fields: 5 of 145
- Cancer Research 969
- Pharmacology 802
- Molecular Biology 3.1k
- Complementary and alternative medicine 316
- Pharmacology 335
Countries citing papers authored by Dongming Xing
This map shows the geographic impact of Dongming Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongming Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongming Xing more than expected).
Fields of papers citing papers by Dongming Xing
This network shows the impact of papers produced by Dongming Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongming Xing. The network helps show where Dongming Xing may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongming Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 218 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lipid metabolism and cancer Hit paper breakdown → | 2020 | 682 |
| 2 | KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase Hit paper breakdown → | 2017 | 396 |
| 3 | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis Hit paper breakdown → | 2020 | 272 |
| 4 | 2005 | 245 | |
| 5 | 2020 | 175 | |
| 6 | 2004 | 167 | |
| 7 | 2003 | 126 | |
| 8 | 2005 | 125 | |
| 9 | 2020 | 119 | |
| 10 | 2020 | 112 | |
| 11 | 2021 | 110 | |
| 12 | The Current and Future Perspectives of Postbiotics Hit paper breakdown → | 2023 | 109 |
| 13 | 2009 | 104 | |
| 14 | New-generation advanced PROTACs as potential therapeutic agents in cancer therapy Hit paper breakdown → | 2024 | 101 |
| 15 | 2004 | 99 | |
| 16 | 2022 | 93 | |
| 17 | 2023 | 92 | |
| 18 | 2007 | 87 | |
| 19 | 2019 | 83 | |
| 20 | 2022 | 81 |
About Dongming Xing
Dongming Xing is a scholar working on Molecular Biology, Pharmacology, Biomedical Engineering, Oncology and Organic Chemistry, having authored 218 papers that have together received 7.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (13 papers), Protein Degradation and Inhibitors (13 papers), Synthesis and biological activity (12 papers), Natural product bioactivities and synthesis (12 papers), Cholesterol and Lipid Metabolism (11 papers), Advanced biosensing and bioanalysis techniques (11 papers), Nanoplatforms for cancer theranostics (10 papers) and Berberine and alkaloids research (9 papers). The work is most often cited by research in Cancer Research (969 citations), Pharmacology (802 citations), Molecular Biology (3.1k citations), Complementary and alternative medicine (316 citations) and Pharmacology (335 citations). Dongming Xing has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lijun Du, Wujun Chen, Zhimin Lu, Daqian Xu, Bing Liang, Xueli Bian, Rui Liu, Ying Meng, Yudong Wu and Renshuai Zhang. Their work appears in journals such as Tsinghua Science & Technology, Biomedical Chromatography, Frontiers in Immunology, European Journal of Medicinal Chemistry and Chinese Journal of Natural Medicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.